Wichtigste Erkenntnisse
- The MENVEO ACWY meningococcal vaccine costs from AED 200–350 per dose at DCDC, while the BEXSERO (Group B) vaccine costs from AED 450–700 per dose — together they cover all five major disease-causing serogroups (A, B, C, W, Y)
- Saudi Arabia mandates the quadrivalent ACWY meningococcal vaccine for all Hajj and Umrah pilgrims aged one year and older, administered at least 10 days before arrival and valid for up to 5 years with conjugate vaccines
- The UAE national immunization program now includes MenACWY vaccination for 11th-grade students (aged 16–18), and many Dubai schools require proof of meningococcal vaccination for enrollment
- Meningococcal disease carries a case fatality rate of 10–15% even with appropriate antibiotic treatment, and up to 20% of survivors experience permanent complications including hearing loss, limb amputation, and neurological damage
- BEXSERO is approved from 2 months of age and requires 2–3 doses depending on age group, while MENVEO ACWY is routinely recommended from age 11–12 with a booster at 16
- Common side effects of both vaccines are mild and temporary — injection site soreness, low-grade fever, and fatigue — typically resolving within 1–2 days
- DCDC Dubai Healthcare City offers walk-in meningococcal vaccination with official certificates issued on-site, essential for Hajj/Umrah visa applications and school enrollment documentation
- Direct billing is available with 20+ insurance providers at DCDC, including Daman, AXA, Bupa, MetLife, and Cigna, potentially reducing out-of-pocket costs to zero for covered preventive immunizations
Meningococcal disease is one of the most dangerous bacterial infections a person can contract — capable of progressing from first symptoms to life-threatening illness within 24 hours, with a fatality rate of 10–15% even when treated promptly with antibiotics. For Dubai residents, the meningococcal vaccine is not only a critical preventive health measure but often a practical requirement: mandatory for Hajj and Umrah travel to Saudi Arabia, increasingly required for UAE school enrollment, and recommended by the WHO for adolescents, university students, and anyone with certain medical conditions. This guide covers the full cost of meningococcal vaccination at DCDC in Dubai Healthcare City — including 2026 pricing for both BEXSERO (Group B) and MENVEO ACWY, the recommended schedule by age, Hajj and school requirements, side effects, and insurance coverage — so you can plan and budget before booking your appointment.
Two distinct vaccines are needed to protect against all major meningococcal serogroups. MENVEO ACWY covers serogroups A, C, W, and Y and is the vaccine required for Hajj and Umrah travel. BEXSERO targets serogroup B, which accounts for the majority of meningococcal disease cases in many countries and is particularly important for infants, adolescents, and university students living in close quarters. At DCDC, both vaccines are available for walk-in administration, with official vaccination certificates issued on-site the same day. Understanding the difference between these two vaccines, their respective costs, and who needs which one is the first step toward making an informed decision about meningococcal protection for yourself or your family.
Meningococcal Vaccine Cost in Dubai: 2026 Pricing Guide
The cost of meningococcal vaccination in Dubai depends primarily on which vaccine you need — MENVEO ACWY or BEXSERO — the number of doses required for your age group, and whether your insurance covers preventive immunization. Below is a transparent breakdown of current pricing at DCDC Dubai Healthcare City for both meningococcal vaccines.
| Vaccine / Service | Price per Dose (AED) | Total Course Cost (AED) | Notes |
|---|---|---|---|
| MENVEO ACWY — single dose (adolescents/adults) | AED 200–350 | AED 200–350 (single dose) or AED 400–700 (primary + booster) | Required for Hajj/Umrah; routine dose at 11–12 years, booster at 16 |
| MENVEO ACWY — children (2–10 years) | AED 200–350 | AED 200–350 | Single dose for children aged 2 and older |
| BEXSERO (Group B) — infants (2–11 months) | AED 450–700 | AED 1,350–2,100 (3 doses + booster) | 3 primary doses plus a booster in the second year of life |
| BEXSERO (Group B) — children (2–10 years) | AED 450–700 | AED 900–1,400 (2 doses) | 2 doses at least 1 month apart |
| BEXSERO (Group B) — adolescents/adults (11+ years) | AED 450–700 | AED 900–1,400 (2 doses) | 2 doses at least 6 months apart for healthy individuals |
| GP consultation (pre-vaccination assessment) | AED 150–300 | — | Reviews medical history, prior vaccinations, and travel requirements |
| Official vaccination certificate | Included | — | Issued on-site; valid for Hajj/Umrah visa applications and school enrollment |
Meningococcal vaccine prices at DCDC Dubai Healthcare City as of July 2026. Prices reflect current clinic rates and may vary based on age group and consultation requirements. Insurance coverage may reduce or eliminate out-of-pocket costs.
At DCDC, MENVEO ACWY is available from AED 200–350 per dose, making it one of the most competitively priced options in Dubai Healthcare City for Hajj and Umrah travelers. BEXSERO (Group B) is priced from AED 450–700 per dose, reflecting its more complex recombinant manufacturing process. Both vaccines are stored in cold-chain certified refrigeration maintained at 2–8 degrees Celsius, ensuring full potency at the time of administration.
BEXSERO vs MENVEO ACWY: Which Meningococcal Vaccine Do You Need?
One of the most common points of confusion about meningococcal vaccination is that no single vaccine covers all disease-causing serogroups. The bacterium Neisseria meningitidis has multiple serogroups, five of which cause the vast majority of invasive disease worldwide: A, B, C, W, and Y. Two separate vaccines are needed to cover all five.
| Feature | MENVEO ACWY | BEXSERO (MenB) |
|---|---|---|
| Serogroups covered | A, C, W, and Y | B only |
| Price per dose at DCDC | AED 200–350 | AED 450–700 |
| Required for Hajj/Umrah | Yes — mandatory for Saudi Arabia entry | No — not required for Hajj/Umrah |
| UAE school enrollment | Required for 11th-grade students under national program | Not currently mandated but recommended |
| Minimum age | 2 months (depending on formulation) | 2 months |
| Number of doses (adolescents/adults) | 1 dose + booster at 16 | 2 doses (6 months apart for healthy individuals) |
| Duration of protection | Up to 5 years (conjugate vaccine) | Duration under ongoing study; booster may be needed |
| Best for | Hajj/Umrah travelers, school requirements, routine adolescent immunization | Infants, university students, immunocompromised individuals, outbreak settings |
Comparison of MENVEO ACWY and BEXSERO meningococcal vaccines available at DCDC. Together they provide coverage against all five major disease-causing serogroups.
In practical terms, most Hajj and Umrah travelers need only MENVEO ACWY, since Saudi Arabia specifically mandates quadrivalent ACWY vaccination. Parents of infants and adolescents, however, should strongly consider BEXSERO as well, since serogroup B accounts for approximately 56% of invasive meningococcal disease cases in children and young adults according to European surveillance data. For comprehensive protection, both vaccines can be administered during the same visit at DCDC, given at different injection sites.
Who Needs the Meningococcal Vaccine?
Meningococcal vaccination is recommended — and in some cases required — for a broader range of people than many Dubai residents realize. The following groups should consider one or both meningococcal vaccines.
Routine Adolescent Immunization
The CDC recommends a first dose of MenACWY at age 11–12, with a booster dose at 16. This timing is designed to provide protection during the peak-risk years of adolescence and early adulthood, when meningococcal disease incidence rises due to social behaviors, communal living, and increased exposure. The UAE national immunization program has adopted a similar recommendation, adding MenACWY vaccination for 11th-grade students (aged 16–18). For families planning their children’s immunization schedule, our complete child vaccination schedule for Dubai covers every recommended vaccine by age, including meningococcal doses.
Hajj and Umrah Travelers
Saudi Arabia mandates quadrivalent ACWY meningococcal vaccination for all pilgrims aged one year and older. The vaccine must be administered at least 10 days before arrival, and certificates issued for conjugate vaccines such as MENVEO are valid for 5 years. This is a non-negotiable entry requirement — without a valid meningococcal vaccination certificate, visa applications for Hajj and Umrah will be rejected.
University and Boarding School Students
Students living in dormitories, shared accommodation, or university halls of residence face elevated meningococcal risk due to close-quarters living and social mixing. Many international universities — particularly in the United States, United Kingdom, and Australia — require proof of both MenACWY and MenB vaccination before enrollment. Parents sending children abroad for higher education should confirm their destination university’s specific requirements well in advance.
Higher-Risk Medical Groups
- Individuals with complement deficiency or taking complement inhibitor medications (e.g., eculizumab, ravulizumab)
- People with functional or anatomical asplenia, including those with sickle cell disease
- Microbiologists routinely exposed to Neisseria meningitidis isolates
- Travelers to the meningitis belt of sub-Saharan Africa, particularly during the dry season (December–June)
- Anyone identified during a meningococcal disease outbreak as a close contact or part of a targeted vaccination campaign
- HIV-positive individuals, who face higher susceptibility to invasive meningococcal disease
Meningococcal Vaccine for Hajj and Umrah: Requirements and Timing
For the thousands of Dubai residents who travel to Saudi Arabia each year for Hajj or Umrah, the meningococcal ACWY vaccine is not optional — it is a mandatory entry requirement enforced at the border. Understanding the specific rules helps you avoid last-minute complications with your visa application.
Saudi Arabia’s Meningococcal Vaccine Requirements (2026)
- Vaccine type: Quadrivalent ACWY meningococcal vaccine (MENVEO or equivalent conjugate vaccine)
- Age requirement: All pilgrims and Hajj workers aged 1 year and older
- Timing: Must be administered at least 10 days before arrival in Saudi Arabia
- Validity: Conjugate vaccines (such as MENVEO) are valid for 5 years from the date of vaccination
- Documentation: An official vaccination certificate must be presented with the visa application; certificates must include the vaccine name, batch number, and date of administration
- Additional vaccines: Saudi authorities also require proof of COVID-19, polio, and (for travelers from endemic countries) yellow fever vaccination
At DCDC, official vaccination certificates that meet Saudi Arabia’s requirements are issued on-site immediately after administration. The certificate includes the vaccine brand (MENVEO ACWY), batch number, date of administration, and the clinic’s MOHAP license number — all the details needed for your Hajj or Umrah visa application. If your previous meningococcal vaccination was more than 5 years ago, you will need a new dose before traveling.
Meningitis Vaccine and UAE School Enrollment Requirements
The UAE has progressively expanded its national immunization schedule to include meningococcal vaccination. As of 2026, the Ministry of Health and Prevention (MOHAP) has added the MenACWY vaccine to the national immunization program for school-age students, specifically targeting 11th-grade students (aged 16–18). This follows global trends recognizing adolescents as a peak-risk group for meningococcal disease.
Schools in Dubai and Abu Dhabi increasingly require proof of meningococcal vaccination as part of the enrollment medical examination, particularly for students entering secondary school. Parents should check with their child’s specific school for current requirements, as implementation varies between emirates and individual institutions. DCDC issues official vaccination records that are accepted by all UAE schools and educational authorities.
Meningococcal Vaccine Schedule by Age Group
The number of doses and timing of meningococcal vaccination depends on the patient’s age and which vaccine is being administered. Below is the recommended schedule for both MENVEO ACWY and BEXSERO, as used at DCDC and aligned with CDC, WHO, and UAE national guidelines. For a broader view of all childhood immunizations, see our travel vaccines guide for Dubai, which covers destination-specific requirements alongside routine immunizations.
MENVEO ACWY Schedule
| Age Group | Doses | Timing | Notes |
|---|---|---|---|
| Infants (2–23 months) | 2–4 doses | Varies by age at first dose | Given as part of infant immunization if indicated |
| Children (2–10 years) | 1 dose | Single dose; booster every 5 years if ongoing risk | Recommended for high-risk children or travel |
| Adolescents (11–12 years) | 1 dose | Routine first dose | Part of UAE national immunization program |
| Adolescents (16 years) | 1 booster | Booster dose at age 16 | Ensures protection through university years |
| Adults (Hajj/Umrah travelers) | 1 dose | At least 10 days before travel; valid 5 years | Mandatory for Saudi Arabia entry |
| High-risk individuals (any age) | 2 doses + boosters | 2 doses 8–12 weeks apart; booster every 5 years | Complement deficiency, asplenia, HIV, microbiologists |
MENVEO ACWY dosing schedule based on CDC and UAE national immunization guidelines. Your doctor at DCDC will confirm the appropriate schedule for your age and risk profile.
BEXSERO (Group B) Schedule
| Age Group | Doses | Timing | Notes |
|---|---|---|---|
| Infants (2‑5 months) | 3 doses + booster | Primary doses at monthly intervals; booster at 12–23 months | Earliest possible protection against serogroup B |
| Infants (6–11 months) | 2 doses + booster | 2 doses at least 2 months apart; booster in second year | Catch-up schedule for older infants |
| Children (12–23 months) | 2 doses + booster | 2 doses at least 2 months apart; booster 12–23 months later | Includes booster to maintain protection |
| Children (2–10 years) | 2 doses | At least 1 month apart | No routine booster currently recommended |
| Adolescents and adults (11+ years) | 2 doses | At least 6 months apart (healthy); 0, 1–2, and 6 months (high-risk: 3 doses) | Recommended for university students and high-risk groups |
BEXSERO dosing schedule based on EMA and CDC guidelines. DCDC stocks BEXSERO for all age groups from 2 months onward.
Meningococcal Vaccine Side Effects: What to Expect
Both MENVEO ACWY and BEXSERO have been extensively studied in clinical trials and post-marketing surveillance involving millions of doses worldwide. Side effects are generally mild and self-limiting, resolving within 1–2 days without medical intervention.
Common Side Effects (Mild and Temporary)
- Injection site pain and tenderness: The most frequently reported side effect for both vaccines, typically resolving within 24–48 hours
- Redness or swelling at the injection site, usually mild and localized
- Low-grade fever: More common with BEXSERO than MENVEO, usually below 38.5 degrees Celsius and resolving within a day
- Fatigue and headache: Reported by some adolescents and adults, typically mild and brief
- Muscle and joint aches: Similar to other intramuscular vaccines, resolving within 1–2 days
- Irritability and crying in infants: Common after BEXSERO in young children, resolving within 24 hours
- Nausea: Occasionally reported, particularly in adolescents and young adults
Managing Side Effects
Prophylactic paracetamol (given at the time of vaccination and repeated as needed over 24 hours) has been shown to reduce fever and injection site pain following BEXSERO without affecting the immune response, and is routinely recommended for infants receiving this vaccine. For adults, over-the-counter pain relief and a cool compress applied to the injection site are usually sufficient. Serious allergic reactions are extremely rare with both vaccines — DCDC’s vaccination team monitors all patients for a brief observation period after administration as a standard safety precaution.
What to Expect at DCDC: Your Meningococcal Vaccination Visit
Getting vaccinated against meningococcal disease at DCDC in Dubai Healthcare City is a straightforward, same-day process. Located in Building 64, Block A of the Al Razi Medical Complex, DCDC offers walk-in vaccination with an average wait time of 15 minutes.
Step 1: Pre-Vaccination Assessment
Your visit begins with a consultation with a general practitioner who reviews your medical history, any prior vaccination records, current medications, and the specific reason for vaccination (Hajj travel, school enrollment, routine immunization, or medical indication). This assessment determines whether you need MENVEO ACWY, BEXSERO, or both, and confirms the appropriate dosing schedule for your age and health status. DCDC’s multilingual medical staff — fluent in Arabic, English, Farsi, Urdu, and Hindi — ensures clear communication regardless of your preferred language.
Step 2: Vaccine Administration
Both MENVEO ACWY and BEXSERO are kept in stock at DCDC in cold-chain certified storage, meaning most patients receive their vaccine on the same day as their consultation without needing a return visit. The injection is administered intramuscularly — in the upper arm for adolescents and adults, or the thigh for infants — and takes only a few seconds. If both vaccines are indicated, they can be given simultaneously at different injection sites during the same visit.
Step 3: Certificate and Follow-Up
Immediately after vaccination, DCDC issues an official vaccination certificate documenting the vaccine brand, batch number, date of administration, and the clinic’s MOHAP license details. For Hajj and Umrah travelers, this certificate is formatted to meet Saudi Arabia’s visa requirements. For parents, the record integrates into your child’s UAE vaccination history for school enrollment purposes. If additional doses are needed, DCDC schedules follow-up appointments and sends SMS or WhatsApp reminders as each due date approaches. Free dedicated parking is available on-site at the Al Razi Medical Complex for every visit.
Book Your Meningococcal Vaccination at DCDC
Walk-in MENVEO ACWY and BEXSERO vaccination at DCDC Dubai Healthcare City. Official certificates for Hajj, Umrah, and school enrollment issued on-site.
Direct billing with 20+ insurance providers. Average wait time: 15 minutes. Free parking on-site.
Insurance Coverage for Meningococcal Vaccine in Dubai
Whether your insurance covers meningococcal vaccination depends on your specific policy type and the reason for vaccination. Many employer-provided health insurance plans in the UAE cover preventive vaccinations — particularly those included in the national immunization schedule — as part of standard wellness benefits. Children’s routine immunizations, including MenACWY, are frequently covered under family and dependent policies.
DCDC offers direct billing with more than 20 insurance providers, including Daman, AXA, Bupa, MetLife, Oman Insurance, Cigna, and Allianz Partners. Before your appointment, DCDC’s insurance coordination team can verify your specific coverage and, where needed, obtain pre-authorization for the full vaccination course in a single approval. For patients whose insurance does not cover meningococcal vaccination — or for self-pay patients — DCDC’s transparent pricing means you know your total cost before the injection is administered. If you are also reviewing other immunizations alongside meningococcal protection, our adult vaccination guide for Dubai covers the full range of recommended vaccines and their insurance implications. With a 4.8/5 Google rating from over 1,000 verified patient reviews, DCDC’s commitment to pricing transparency and clinical quality is consistently reflected in patient feedback.
Understanding Meningococcal Disease: Why Vaccination Matters
Meningococcal disease is caused by the bacterium Neisseria meningitidis and manifests primarily as bacterial meningitis (infection of the membranes surrounding the brain and spinal cord) or meningococcal septicemia (bloodstream infection). What makes this disease uniquely dangerous is its speed: a patient can progress from initial flu-like symptoms — fever, headache, stiff neck — to septic shock, organ failure, and death within 24 hours.
According to the WHO, meningococcal disease carries a case fatality rate of 10–15% even with appropriate antibiotic treatment in a hospital setting. Among survivors, approximately 10–20% experience permanent sequelae including hearing loss, brain damage, limb amputation due to tissue necrosis, kidney damage, and chronic neurological conditions. The disease disproportionately affects infants under 1 year, adolescents aged 15–19, and young adults — though outbreaks can occur in any age group, particularly in crowded settings such as dormitories, military barracks, and mass gatherings like the Hajj pilgrimage.
CDC surveillance data from 2025 recorded 463 confirmed and probable cases of invasive meningococcal disease in the United States alone — the second-highest annual total since 2013, indicating a resurgence after years of declining incidence. European surveillance data from 2024 showed notification rates reaching their highest level in five years. These trends reinforce the importance of maintaining up-to-date meningococcal vaccination, particularly for the age groups and risk categories most vulnerable to severe outcomes.
Dr. Hadeel Elnur on Meningococcal Vaccination at DCDC
According to Dr. Hadeel Elnur, General Practitioner at DCDC Dubai Healthcare City, "Meningococcal disease is one of the infections I take most seriously in clinical practice because of how rapidly it can become life-threatening. Parents often assume meningitis is rare, but the reality is that the bacterium is carried asymptomatically in the nose and throat of approximately 10% of the population at any given time, and transmission occurs through everyday activities — coughing, kissing, sharing utensils. What distinguishes those who develop invasive disease from carriers is often just a matter of immune timing and serogroup exposure."
"I recommend both MENVEO ACWY and BEXSERO for adolescents and young adults heading to university, whether in the UAE or abroad. For Hajj and Umrah travelers, I always emphasize the 10-day lead time — patients occasionally come in just days before departure, not realizing the vaccine needs time to generate a protective immune response before they enter a mass gathering of millions of people. At DCDC, we stock both vaccines for same-day administration and issue the official certificates immediately, so there is no reason to delay when the stakes of meningococcal disease are this serious."
How Long Does the Meningococcal Vaccine Last?
The duration of protection varies by vaccine type. For MENVEO ACWY, conjugate vaccine protection is generally considered to last up to 5 years, which is why Saudi Arabia accepts certificates valid for 5 years from the date of vaccination. For individuals with ongoing risk factors — such as complement deficiency or regular travel to high-risk areas — booster doses every 5 years are recommended to maintain protective antibody levels.
For BEXSERO (Group B), the long-term duration of protection is still being studied in ongoing clinical trials and real-world surveillance programs. Current evidence suggests that antibody levels decline over time after the primary series, which is why booster doses may be recommended for individuals who remain at elevated risk. The CDC and European Medicines Agency continue to refine their guidance on BEXSERO booster timing as more long-term data becomes available. Your doctor at DCDC can advise on whether a booster is appropriate based on your individual risk profile and how long ago you completed your primary course.
Factors That Affect Meningococcal Vaccine Cost in Dubai
Several variables determine your total out-of-pocket cost for meningococcal vaccination in Dubai. Understanding these factors helps you budget accurately before booking.
- Vaccine type: MENVEO ACWY is significantly less expensive per dose than BEXSERO, reflecting differences in manufacturing complexity. If you only need ACWY coverage (e.g., for Hajj travel), your total cost will be lower than if you also need serogroup B protection.
- Number of doses required: Infants starting BEXSERO at 2 months need 3 primary doses plus a booster, making the total course more expensive than the 2-dose adolescent schedule. MENVEO ACWY typically requires just 1–2 doses for routine immunization.
- Patient age: The dosing schedule — and therefore the total cost — depends on the patient’s age at the time of the first dose. Younger infants require more doses of BEXSERO than older children or adults.
- Insurance coverage: Patients with insurance that covers preventive immunization may pay nothing out of pocket. DCDC’s direct billing with 20+ insurers streamlines the process.
- Consultation fees: Some clinics bundle the pre-vaccination assessment into the dose price; others charge separately. Always confirm total costs before proceeding.
- Provider type: Government health centers, private polyclinics, and premium hospital groups price meningococcal vaccination differently based on overhead and service model.
Protect Your Family Against Meningococcal Disease
Schedule MENVEO ACWY or BEXSERO vaccination at DCDC Dubai Healthcare City. Walk-in appointments available Saturday through Friday.
MOHAP-licensed facility with 98% patient satisfaction. Official certificates for Hajj, Umrah, and school enrollment.
Frequently Asked Questions About Meningococcal Vaccine Cost in Dubai
Below are answers to the most commonly asked questions about meningococcal vaccine cost, requirements, and scheduling in Dubai.
Verwandte Leistungen im DCDC
Fachkundige Betreuung und moderne Diagnostik in Dubai Healthcare City
Häufig gestellte Fragen
Take the Next Step: Schedule Your Meningococcal Vaccination
Meningococcal disease remains one of the most rapidly fatal bacterial infections a person can encounter, yet it is also one of the most preventable through vaccination. Whether you need MENVEO ACWY for an upcoming Hajj or Umrah pilgrimage, BEXSERO to protect an infant or university-bound adolescent against serogroup B, or both vaccines for comprehensive coverage, understanding the costs, schedule, and requirements in advance lets you plan with confidence rather than scrambling at the last minute.
For Dubai residents, the practical considerations are clear: Saudi Arabia’s mandatory ACWY requirement is non-negotiable for Hajj and Umrah travel, the UAE’s national immunization program now includes MenACWY for school-age adolescents, and international universities increasingly require both ACWY and serogroup B vaccination for enrollment. Addressing these requirements early — particularly the 10-day minimum lead time before travel — prevents delays that could disrupt your plans.
At DCDC Dubai Healthcare City, our team provides meningococcal vaccination in a MOHAP-licensed facility with cold-chain certified vaccine storage, walk-in availability, and direct billing with over 20 insurance providers. Official vaccination certificates for Hajj, Umrah, and school enrollment are issued on-site the same day. Whether you are booking for yourself, your child, or your entire family before travel season, we are here to guide you through every step.
Quellen und Referenzen
Dieser Artikel wurde von unserem medizinischen Team überprüft und bezieht sich auf folgende Quellen:
- World Health Organization — Meningococcal Vaccines: WHO Position Paper
- CDC — Meningococcal Vaccine Recommendations
- CDC — Meningococcal Disease Surveillance and Trends
- European Medicines Agency — BEXSERO Product Information
- CDC Yellow Book — Saudi Arabia: Hajj and Umrah Pilgrimages
- MOHAP UAE — National Immunization Program Updates
- Meningitis Research Foundation — Vaccination for Hajj and Umrah Pilgrims
Medizinische Inhalte auf dieser Website werden von DHA-lizenzierten Ärzten überprüft. Siehe unsere redaktionelle Richtlinien für weitere Informationen.
Verfasst von
Dr. Hadeel Elnur
General Practitioner
MD, General Practice
Dr. Hadeel Elnur is a General Practitioner at Doctors Clinic Diagnostic Center (DCDC) in Dubai Healthcare City.
Related Articles
Child Vaccination Schedule Dubai: Full Guide
Travel Vaccines Dubai: Required Shots
Adult Vaccines Dubai: Schedule & Cost
Hepatitis B Vaccine Dubai: Cost & Guide
Mehr in Vaccination
© 2026 Doctors Clinic Diagnostic Center (DCDC), Dubai Healthcare City. Originally published at https://doctorsclinicdubai.ae/blog/meningococcal-vaccine-dubai-guide. All rights reserved. Unauthorized reproduction is prohibited.